Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03827291 · ClinicalTrials.gov registry record · Phase 4
QL Block With Exparel in Colectomy
A Phase 4 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 4
- Development phase
- 35
- Enrollment target
NCT03827291 is a Phase 4 study that has completed, run by Duke University. The registered enrollment target is 35 participants.
The verdict
NCT03827291, a Phase 4 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 35 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if using a different type of injection of local anesthestic (pain medicine) in between the muscle layers of the abdominal wall (called a quadratus lumborum block) will improve pain control and be easier to manage after surgery than the current standard of care epidural (spinal injection) pain relief for patients undergoing laparoscopy colectomy.
Interventions
- DRUG Exparel
- OTHER Thoracic epidural analgesia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-10-31 |
| Est. Completion | 2022-12-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03827291
The ClinicalTrials.gov registry entry for NCT03827291 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 35 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Exparel is the first listed.
NCT03827291 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03827291 about?
NCT03827291 is a clinical study titled "QL Block With Exparel in Colectomy". The purpose of this study is to determine if using a different type of injection of local anesthestic (pain medicine) in between the muscle layers of the abdominal wall (called a quadratus lumborum block) will improve pain control and be easier to manage after surgery than the current standard of ca...
What is the current status of trial NCT03827291?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 35 participants. The study started on 2019-10-31. Estimated completion is 2022-12-09.
What interventions are being tested in trial NCT03827291?
The interventions under investigation include: Exparel (DRUG), Thoracic epidural analgesia (OTHER).
Who is sponsoring clinical trial NCT03827291?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.